Tracked deals
11
11 tracked deals across 2021-2026.
Lake Worth, Florida, United States
Globally integrated clinical research site organization comprised of dedicated and embedded research centers across North America, conducting 5,000+ Phase I–IV trials to advance innovative medical therapies.
Tracked deals
11
11 tracked deals across 2021-2026.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Addon
8 addon · 3 buyout
Last 6 years
Supporting Data
Headlands Research announced the acquisition of Clinical Trials Research (CTR), a privately owned clinical research organization with locations in Sacramento and Lincoln, California. The sites will be rebranded as Headlands Research – Sacramento and Headlands Research – CTR Lincoln, expanding Headlands’ California presence and cardiometabolic therapeutic area capabilities. Financial terms were not disclosed.
Headlands Research has acquired CMRCenter (CMRC), a high-performing clinical research site in San Juan, Puerto Rico, expanding Headlands' site network into the Caribbean and bringing its footprint to 22 sites across the United States, Canada, and Puerto Rico. The deal provides biopharma sponsors a single-contract gateway to a large Hispanic patient population and is intended to accelerate enrollment for vaccine, CNS, and specialty studies.
Headlands Research has acquired Trial Management Associates (TMA), a multi-site clinical research company with locations in Wilmington, North Carolina and Myrtle Beach, South Carolina. The deal expands Headlands Research's network to 21 sites across the United States and Canada and strengthens its southeastern U.S. footprint and clinical capabilities.
Headlands Research, a multinational network of clinical trial sites, has acquired Pharmasite Research, a Maryland-based clinical trial site focused on mental illness and central nervous system (CNS) disorders. The deal expands Headlands' therapeutic capabilities in mental health and extends its site network's reach in the Mid-Atlantic, bringing the network to 18 sites across the United States and Canada.
Headlands Research has acquired Clinical Research Professionals, a St. Louis–area clinical research site, expanding Headlands' network and geographic reach. The acquisition adds experienced investigators and capabilities across therapeutic areas including gastroenterology, neurology, and vaccines, supporting increased participant recruitment and trial capacity.
Headlands Research has acquired AMCR Institute, a San Diego–based clinical research site specializing in metabolic, endocrine and medical device research (including continuous glucose monitors). The site will operate as Headlands Research AMCR Institute as part of Headlands' expanding network of clinical trial sites to support more trials and broaden therapeutic and device capabilities.
Headlands Research, a multinational clinical trial site network, has acquired Clinvest Research, a Springfield, Missouri-based clinical research site that has conducted over 600 trials since 1996. The deal expands Headlands' chronic pain and endocrinology capabilities and increases participant access for trials in the United States.
Headlands Research acquired an established clinical research site now operating as Headlands Research Eastern Massachusetts. The site — led by neurologist Dr. Donald Marks and specializing in neurodegenerative diseases such as Alzheimer’s and Parkinson’s — broadens Headlands’ neurology research capabilities and expands its clinical trial site network in Eastern Massachusetts.
Headlands Research, a KKR-backed clinical trial site network based in San Francisco, acquired Peninsula Research Associates (PRA) of Rolling Hills, California. The undisclosed transaction expands Headlands' clinical research capabilities in allergy and asthma, pediatric studies and vaccine trials while extending its Southern California footprint.
Headlands Research, a KKR-backed clinical research site organization based in San Francisco, has acquired Summit Research Network in Portland, Oregon, expanding Headlands' site footprint and expertise in neurology, psychiatry and memory-health research. The deal grows Headlands' global network to 15 clinical trial sites and accompanies the launch of a fourth Horizons site in Scottsdale, Arizona.
Headlands Research, a San Francisco–based clinical research site organization backed by KKR, has acquired Artemis Institute for Clinical Research, a multi-site clinical trial provider with locations in San Diego and Riverside, California. The acquisition expands Headlands' global footprint to 13 clinical trial sites and adds Artemis' expertise across psychiatry, neurology, vaccine and medical device trials while supporting Headlands' commitment to diversity in clinical trial enrollment.
Turn tracked acquisition activity into an outreach-ready buyer list.